High temporal resolution imaging reveals endosomal membrane penetration and escape of adenoviruses in real time

Methods in Molecular Biology

Volumn 1064, Issue , 2013, Pages 211-226

  Martinez, Ruben ^a   Burrage, Andrew M ^b   Wiethoff, Christopher M ^b   Wodrich, Harald ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenovirus; Endosomal escape; Galectin 3; Live cell imaging; Membrane damage; Trafficking; Virus entry

Indexed keywords

GALACTOSE; GALECTIN 3; MEMBRANE PROTEIN;

ADENOVIRUS; ARTICLE; CELL LINE; CONTROLLED STUDY; ENDOSOME; HIGH TEMPORAL RESOLUTION IMAGING; IMAGING; MEMBRANE RUPTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CAPSID; VIRUS ENTRY;

ADENOVIRIDAE; ENDOSOMES; FLOW CYTOMETRY; HUMANS; INTRACELLULAR MEMBRANES; MICROSCOPY, CONFOCAL; MOLECULAR IMAGING;

EID: 84884191845     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-601-6_15     Document Type: Article

References (19)

1. Tsai B (2007) Penetration of nonenveloped viruses into the cytoplasm. Annu Rev Cell Dev Biol 23:23-43
2. Ginsberg HS, Horswood RL, Chanock RM et al (1990) Role of early genes in pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 87(16):6191-6195
3. Aldhamen YA, Seregin SS, Amalfitano A (2011) Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm. Front Immunol 2:40
4. Wiethoff CM, Wodrich H, Gerace L et al (2005) Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 79(4):1992-2000
5. Wodrich H, Henaff D, Jammart B et al (2010) A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog 6(3):e1000808
6. Maier O, Galan DL, Wodrich H et al (2010) An N-terminal domain of adenovirus protein VI fragments membranes by inducing positive membrane curvature. Virology 402(1): 11-19
7. Barlan AU, Danthi P, Wiethoff CM (2011) Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome. Virology 412(2):306-314
8. Barlan AU, Griffin TM, McGuire KA et al (2011) Adenovirus membrane penetration activates the NLRP3 inflammasome. J Virol 85(1):146-155
9. McGuire KA, Barlan AU, Griffin TM et al (2011) Adenovirus type 5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress and production of reactive oxygen species. J Virol 85(20):10806-10813
10. Maier O, Marvin SA, Wodrich H et al (2012) Spatiotemporal dynamics of adenovirus membrane rupture and endosomal escape. J Virol 86(19):10821-10828
11. Paz I, Sachse M, Dupont N et al (2010) Galectin-3, a marker for vacuole lysis by invasive pathogens. Cell Microbiol 12(4):530-544
12. Dupont N, Lacas-Gervais S, Bertout J et al (2009) Shigella phagocytic vacuolar membrane remnants participate in the cellular response to pathogen invasion and are regulated by autophagy. Cell Host Microbe 6(2):137-149
13. Mittereder N, March KL, Trapnell BC (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 70(11):7498-7509
14. Rubin RW, Weiss GD (1975) Direct biochemical measurements of microtubule assembly and disassembly in Chinese hamster ovary cells. The effect of intercellular contact, cold, D2O, and N6, O2′-dibutyryl cyclic adenosine monophosphate. J Cell Biol 64(1):42-53
15. Greber UF, Webster P, Weber J et al (1996) The role of the adenovirus protease on virus entry into cells. EMBO J 15(8):1766-1777
16. Weber J (1976) Genetic analysis of adenovirus type 2 III. Temperature sensitivity of processing viral proteins. J Virol 17(2):462-471
17. Barry MA, Weaver EA, Hofherr SE (2010) Rescue, amplification, purification, and PEGylation of replication defective firstgeneration adenoviral vectors. Methods Mol Biol 651:227-239
18. Jager L, Hausl MA, Rauschhuber C et al (2009) A rapid protocol for construction and production of high-capacity adenoviral vectors. Nat Protoc 4(4):547-564
19. Tollefson AE, Kuppuswamy M, Shashkova EV et al (2007) Preparation and titration of CsCl-banded adenovirus stocks. Methods Mol Med 130:223-235